Goodwin, MoFo Guide Fibrosis Biotech's $90M IPO Plans
Clinical-stage biopharmaceutical company Pliant Therapeutics said Tuesday it plans to raise roughly $90 million in a Goodwin Procter- and Morrison & Foerster-steered initial public offering, plus an additional $10 million in...To view the full article, register now.
Already a subscriber? Click here to view full article